Search

Home > News & Events > Current News

Current News

Current SATVI news

Vacancy Research Pharmacist
Tuesday, November 21, 2017 - 12:15

We have a vacancy for a Research Pharmacist at our Worcester Field site. NOW CLOSED

New Gobal commitment to end TB
Monday, November 20, 2017 - 08:30

On Friday 17 November 75 ministers announced a landmark agreement to take urgent action to end tuberculosis (TB) by 2030 at the conclusion of a World Health Organization (WHO) conference in Moscow, Russia, on eradicating the world's deadliest infectious disease.

9 November 2017 Research Published: TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
Thursday, November 9, 2017 - 14:15

Associate Professor Tom Scriba has collaborated with the authors of a research paper titled: "TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development" appearing in the Frontiers in Immunology Journal.

25 October 2017 Research Published Polyfunctional CD4+TCells as targets for vaccination
Monday, November 6, 2017 - 14:45

Associate Professor Tom Scriba has co authored a research paper titled "Polyfunctional CD4+T Cells as targets for Tuberculosis Vaccination" appearing in the Frontiers in Immunology Journal.

5 October 2017 RESEARCH: Safety and Immunogenicity Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 Randomized Controlled Trial
Thursday, October 5, 2017 - 11:30

SATVI authors Dr Elisa Nemes, Prof Mark Hatherill, Associate Prof Tom Scriba, Dr Michele Tameris, Humphrey Mulenga and Danelle Van As have published a research paper titled: "Safety and Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 randomized controlled trial" appearing in the Infectious Disease Journal (Oxford).

3 October 2017 Research: Host blood signatures RNA predict the outcome of tuberculosis treatment
Tuesday, October 3, 2017 - 10:30

Associate Professor Tom Scriba has co-authored a article titled: "Host blood RNA predict the outcome of tuberculosis treatment" appearing in the Tuberculosis Journal.

21 September 2017 Vacancy Research Officer: Systems Immunology
Thursday, September 21, 2017 - 18:15

SATVI invites applications for the position of Research Officer: Systems Immunology at its Cape Town offices. CLOSED.

14 September 2017 Research: Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
Friday, September 15, 2017 - 09:00

SATVI authors have published a research paper titled: "Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population" appearing in the PLoS ONE Journal.

8 September 2017 Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis
Friday, September 8, 2017 - 08:00

Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a research paper titled "A Functional Toll-interacting Protein variant with Bacillus Calmette-Guerin specific immune responses and Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.

7 September 2017 Research Published: Identifying specificity groups in T cell receptor repertoire
Thursday, September 7, 2017 - 17:15

Associate Professor Tom Scriba has co-authored a research paper titled "Identifying specificity groups in the T Cell receptor repertoire" appearing in the Nature Journal.

6 September 2017 Research Published: Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice
Wednesday, September 6, 2017 - 20:15

SATVI authors Associate Professor Tom Scriba, Dr Stanley Mbandi Kimbung, Fatoumatta Darboe and Dr Adam Penn-Nicholson have co-authored a paper titled "Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice" appearing in the Mucosol Immunology Journal.

6 September 2017 SATVI marks 3000th patient screened in CORTIS HR study.
Wednesday, September 6, 2017 - 19:00

SATVI recently marked the 3 000th patient who had been screened for participation in the Correlates of Risk of TB study (CORTIS-01).  

Pages